Index NDX, S&P 500
P/E 41.26
EPS (ttm) 10.36
Insider Own 0.99%
Shs Outstand 82.04M
Perf Week 1.39%
Market Cap 35.02B
Forward P/E 35.69
EPS next Y 11.98
Insider Trans -0.10%
Shs Float 81.08M
Perf Month 2.80%
Income 866.24M
PEG 3.17
EPS next Q 2.40
Inst Own 91.23%
Short Float 2.00%
Perf Quarter -9.47%
Sales 3.84B
P/S 9.11
EPS this Y 3.94%
Inst Trans -2.53%
Short Ratio 2.74
Perf Half Y -14.10%
Book/sh 19.72
P/B 21.68
EPS next Y 14.59%
ROA 26.91%
Short Interest 1.62M
Perf Year -17.60%
Cash/sh 3.77
P/C 113.46
EPS next 5Y 13.00%
ROE 59.42%
52W Range 398.50 - 583.39
Perf YTD -22.95%
Dividend Est. -
P/FCF 44.18
EPS past 5Y 18.76%
ROI 38.56%
52W High -26.70%
Beta 1.37
Dividend TTM -
Quick Ratio 0.98
Sales past 5Y 10.69%
Gross Margin 60.72%
52W Low 7.31%
ATR (14) 11.03
Dividend Ex-Date -
Current Ratio 1.36
EPS Y/Y TTM 5.62%
Oper. Margin 28.93%
RSI (14) 46.98
Volatility 2.11% 2.42%
Employees 11000
Debt/Eq 0.62
Sales Y/Y TTM 7.16%
Profit Margin 22.53%
Recom 2.31
Target Price 495.73
Option/Short Yes / Yes
LT Debt/Eq 0.39
EPS Q/Q 10.95%
Payout 0.00%
Rel Volume 0.52
Prev Close 434.43
Sales Surprise -0.49%
EPS Surprise 4.46%
Sales Q/Q 6.56%
Earnings Oct 31 BMO
Avg Volume 591.97K
Price 427.64
SMA20 0.51%
SMA50 -4.49%
SMA200 -12.64%
Trades
Volume 252,534
Change -1.56%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-02-24 Initiated
Leerink Partners
Outperform
$500
Jul-25-24 Initiated
BTIG Research
Buy
$580
Jan-30-24 Downgrade
Piper Sandler
Overweight → Neutral
$525
Dec-07-23 Initiated
Exane BNP Paribas
Outperform
$602
Dec-04-23 Upgrade
Cleveland Research
Neutral → Buy
Aug-02-23 Downgrade
Atlantic Equities
Overweight → Neutral
$610
Jul-25-22 Downgrade
Stifel
Buy → Hold
$415
Jul-21-22 Upgrade
Goldman
Neutral → Buy
$530 → $435
Jul-12-22 Initiated
Piper Sandler
Overweight
$440
May-05-22 Downgrade
BofA Securities
Buy → Neutral
$550 → $470
Feb-08-22 Initiated
Atlantic Equities
Overweight
$650
Nov-18-21 Initiated
Morgan Stanley
Overweight
Aug-05-21 Resumed
Credit Suisse
Outperform
$735
Jul-12-21 Downgrade
Guggenheim
Buy → Neutral
Feb-17-21 Initiated
Barclays
Overweight
$600
Sep-09-19 Initiated
Goldman
Neutral
$277
May-23-19 Initiated
Guggenheim
Buy
$276
Nov-02-18 Reiterated
BofA/Merrill
Buy
$275 → $235
May-07-18 Reiterated
Stifel
Buy
$215 → $225
Jan-16-18 Initiated
Piper Jaffray
Overweight
$200
Show Previous Ratings
Nov-27-24 09:00AM
Nov-21-24 07:30AM
Nov-07-24 08:44AM
Nov-06-24 04:11AM
Nov-05-24 09:53AM
01:24PM
Loading…
Nov-01-24 01:24PM
03:05AM
03:01AM
(Thomson Reuters StreetEvents)
Oct-31-24 01:16PM
(Morningstar Research) -9.79%
01:15PM
09:30AM
07:40AM
06:41AM
(Associated Press Finance)
06:30AM
Oct-28-24 09:16AM
10:01AM
Loading…
Oct-24-24 10:01AM
Oct-17-24 11:43AM
Oct-11-24 09:06AM
Oct-10-24 10:55AM
Oct-08-24 10:16AM
Oct-06-24 12:53PM
Sep-30-24 02:00PM
Sep-18-24 10:48PM
Sep-05-24 11:31AM
Aug-28-24 10:03AM
Aug-23-24 04:34PM
Aug-21-24 04:15PM
Aug-13-24 08:28AM
Aug-09-24 09:58AM
Aug-07-24 06:09AM
(Thomson Reuters StreetEvents)
09:47AM
Loading…
Aug-06-24 09:47AM
09:30AM
07:40AM
06:36AM
(Associated Press Finance)
06:30AM
Aug-01-24 09:15AM
Jul-30-24 05:53PM
10:01AM
07:00AM
Jul-22-24 09:56AM
Jul-08-24 03:44AM
Jul-02-24 07:26AM
Jun-24-24 11:00AM
Jun-21-24 11:36AM
Jun-19-24 01:53PM
Jun-06-24 08:55AM
Jun-04-24 07:00AM
May-31-24 11:31AM
May-29-24 06:00AM
May-25-24 03:00PM
May-20-24 11:18AM
May-14-24 02:00PM
08:27AM
May-13-24 02:25PM
May-04-24 07:38AM
May-02-24 02:22PM
02:17PM
10:31AM
10:30AM
10:20AM
09:46AM
09:23AM
03:08AM
May-01-24 11:28PM
(Thomson Reuters StreetEvents) -5.02%
02:31PM
10:41AM
09:30AM
08:11AM
07:52AM
07:40AM
07:10AM
06:38AM
(Associated Press Finance)
06:30AM
Apr-30-24 10:02AM
Apr-28-24 06:32PM
Apr-26-24 09:15AM
Apr-24-24 12:01PM
Apr-19-24 07:56AM
Apr-12-24 01:53PM
Apr-09-24 06:00PM
12:00PM
Apr-05-24 12:10PM
Apr-04-24 04:30PM
Apr-02-24 08:31AM
Mar-29-24 02:15AM
Mar-21-24 05:42AM
Mar-08-24 03:01AM
Mar-06-24 11:30AM
Mar-05-24 03:05AM
Feb-22-24 03:46AM
Feb-20-24 02:00PM
Feb-18-24 01:26PM
Feb-16-24 12:56PM
Feb-15-24 11:53AM
07:00AM
Feb-10-24 02:07AM
Feb-09-24 03:35PM
Feb-08-24 10:34AM
Feb-06-24 02:25PM
(Investor's Business Daily)
08:46AM
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Vandebroek Sophie V. Director Nov 27 '24 Sale 420.44 344 144,630 905 Nov 29 05:00 PM Vandebroek Sophie V. Director Nov 27 '24 Proposed Sale 420.44 344 144,630 Nov 27 04:36 PM SZOSTAK M ANNE Director Sep 06 '24 Sale 469.37 500 234,686 0 Sep 09 04:18 PM M. Anne Szostak Director Sep 06 '24 Proposed Sale 469.78 500 234,890 Sep 06 04:36 PM Schreck Michael Executive Vice President Sep 01 '24 Option Exercise 0.00 164 0 961 Sep 04 08:20 PM Smith Martin Alexander Executive Vice President Sep 01 '24 Option Exercise 0.00 18 0 515 Sep 04 08:03 PM MCKEON BRIAN P EVP, CFO and Treasurer Aug 05 '24 Option Exercise 0.00 192 0 31,049 Aug 07 05:01 PM MAZELSKY JONATHAN JAY President and CEO Aug 05 '24 Option Exercise 0.00 384 0 81,903 Aug 07 05:00 PM Claflin Bruce L. Director May 17 '24 Sale 540.80 200 108,160 161 May 20 05:00 PM Vandebroek Sophie V. Director May 06 '24 Option Exercise 0.00 257 0 1,473 May 08 07:02 PM SZOSTAK M ANNE Director May 06 '24 Option Exercise 0.00 257 0 257 May 08 07:02 PM Kingsley Lawrence D Director May 06 '24 Option Exercise 0.00 339 0 8,883 May 08 07:02 PM ESSIG STUART Director May 06 '24 Option Exercise 0.00 257 0 1,974 May 08 07:01 PM COLLINS Asha Director May 06 '24 Option Exercise 0.00 257 0 779 May 08 07:01 PM Britt Irene Chang Director May 06 '24 Option Exercise 0.00 208 0 208 May 08 07:00 PM AYERS JONATHAN W Director May 06 '24 Option Exercise 0.00 257 0 265,651 May 08 07:00 PM POLEWACZYK JAMES F Executive Vice President Mar 06 '24 Option Exercise 422.45 8,104 3,423,547 18,815 Mar 07 05:00 PM POLEWACZYK JAMES F Executive Vice President Mar 06 '24 Sale 558.44 8,104 4,525,596 10,711 Mar 07 05:00 PM Vandebroek Sophie V. Director Mar 05 '24 Option Exercise 245.79 1,404 345,089 2,620 Mar 07 05:00 PM Vandebroek Sophie V. Director Mar 05 '24 Sale 562.98 1,404 790,427 1,216 Mar 07 05:00 PM MAZELSKY JONATHAN JAY President and CEO Feb 21 '24 Option Exercise 206.94 483 99,952 82,047 Feb 22 05:02 PM Underberg Sharon E. EVP, GC & Corporate Secretary Feb 16 '24 Option Exercise 206.94 483 99,952 5,595 Feb 20 05:01 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 15 '24 Option Exercise 206.94 483 99,952 30,835 Feb 20 05:00 PM Smith Martin Alexander Executive Vice President Feb 14 '24 Option Exercise 0.00 337 0 583 Feb 16 05:58 PM Schreck Michael Executive Vice President Feb 14 '24 Option Exercise 0.00 368 0 903 Feb 16 05:58 PM POLEWACZYK JAMES F Executive Vice President Feb 14 '24 Option Exercise 0.00 927 0 10,990 Feb 16 05:57 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 14 '24 Option Exercise 0.00 1,731 0 31,449 Feb 16 05:57 PM MAZELSKY JONATHAN JAY President and CEO Feb 14 '24 Option Exercise 0.00 4,156 0 83,403 Feb 16 05:56 PM Lane Michael Executive Vice President Feb 14 '24 Option Exercise 0.00 939 0 6,726 Feb 16 05:56 PM Johnson Michael Perkins EVP and CHRO Feb 14 '24 Option Exercise 0.00 176 0 243 Feb 16 05:56 PM Hunt Nimrata Executive Vice President Feb 14 '24 Option Exercise 0.00 664 0 11,731 Feb 16 05:55 PM FENNELL GEORGE SVP, Chief Revenue Officer Feb 14 '24 Option Exercise 0.00 370 0 7,082 Feb 16 05:55 PM Erickson Michael G Executive Vice President Feb 14 '24 Option Exercise 0.00 462 0 10,801 Feb 16 05:54 PM FENNELL GEORGE SVP, Chief Revenue Officer Feb 08 '24 Option Exercise 62.00 9,810 608,220 14,910 Feb 09 05:03 PM FENNELL GEORGE SVP, Chief Revenue Officer Feb 08 '24 Sale 573.87 8,198 4,704,559 6,712 Feb 09 05:03 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 07 '24 Option Exercise 141.60 23,326 3,302,962 53,044 Feb 09 05:01 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 07 '24 Sale 570.01 23,326 13,295,975 29,718 Feb 09 05:01 PM MAZELSKY JONATHAN JAY President and CEO Feb 07 '24 Option Exercise 67.85 12,000 814,200 91,247 Feb 09 05:00 PM MAZELSKY JONATHAN JAY President and CEO Feb 07 '24 Sale 572.61 12,000 6,871,319 79,247 Feb 09 05:00 PM POLEWACZYK JAMES F Executive Vice President Dec 07 '23 Option Exercise 253.92 11,636 2,954,645 21,686 Dec 08 05:00 PM POLEWACZYK JAMES F Executive Vice President Dec 07 '23 Sale 521.79 11,636 6,071,500 10,050 Dec 08 05:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite